Thank you, Dr. Gralow. It was truly our honor to recognize your exceptional leadership and lifelong dedication to advancing global oncology. Your commitment to mentorship, collaboration, and improving cancer care continues to inspire us and so many others around the world.

kinda chic to build a platform @MedNewsWeek powered by people, ideas, mentorship, and impact. Behind every keynote, research project, educational series, campaign, and collaboration is a group of people choosing to show up, learn from one another, and think bigger.

CML care is rapidly advancing. 🎙️ In this @MedNewsWeek × @oncodaily episode, Jorge Cortes, MD, discusses modern treatment strategies, TKIs, molecular monitoring, treatment resistance and the role of AI in personalized care. Watch the full keynote: piped.video/dtWA2bQ2nX4?is…

It was a tremendous honor to host Dr. Kami Maddocks and Dr. Peter Martin, two global leaders who have helped shape the field of lymphoma. We are incredibly grateful for the opportunity to learn directly from their expertise and perspectives on where mantle cell lymphoma care is heading. This is what MedNews Week is all about—bringing together extraordinary leaders, creating meaningful scientific dialogue, and making those conversations accessible to a global community. Thank you again, Dr. Maddocks and Dr. Martin, for your time, your insights, and all that you continue to do for our field and our patients. We can’t wait to share the full episode with the MedNews Week global audience soon! 🎙️🌎 #MedNewsWeek #MantleCellLymphoma #Lymphoma #Hematology #Oncology #CART @kmaddmd @OhioStateMedOnc @OhioStatePIIO @OSUhemoncfellow @NYULH_DeptofMed @Perlmutter_CC @nyulangone @nyugrossman @Pelotonia @MedNewsWeek

Not often do we get surgeons radiation oncologists and medical oncologists together for a sharing Masterclass on #NasopharyngealCarcinoma #NPC supposed by TopAlliance Excellent lectures on what’s in the horizon by Dr James Chow Prof Darren Lim Case discussions by Prof Dora Kwong @hkumed Bottomline: Understanding Clinical and Biological Heterogeneity is key in #NPC

Every so often, you have the privilege of working with someone whose impact is difficult to capture in a CV. Dr. Zara Baloch is one of those people. Over the time I’ve had the privilege of working with Zara at MedNews Week, I’ve watched her grow into an exceptional leader, scholar, communicator, and teammate. She brings a rare combination of intellectual curiosity, meticulous attention to detail, humility, warmth, and an extraordinary ability to adapt and grow. But what distinguishes Zara most is the effect she has on the people around her. She is the person who notices what others miss, steps forward when something needs to be done, brings people together, and quietly raises the standard for everyone on the team. She leads without needing the spotlight and approaches every opportunity with genuine curiosity and a desire to become better. In many ways, she has become one of those invaluable “glue people” every successful team and institution needs—and very few are fortunate enough to find. I have seen Zara take on increasingly complex responsibilities in research, medical education, interviewing physicians and scientists, and organizational leadership, and with each new challenge she has continued to evolve. What has remained constant is her character: thoughtful, dependable, kind, deeply committed to others, and relentlessly willing to learn. As she enters the #Match2027 cycle in Internal Medicine, I could not be more excited to see where her journey takes her. I have every confidence that she will bring the same scholarship, humanity, leadership, and collaborative spirit to residency that she has brought to our organization. Internal Medicine programs: take note of Dr. Zara Baloch. Any institution fortunate enough to train her will be gaining not only a talented future physician, but the kind of colleague who makes the people and the institution around her better. Proud of how far you’ve come, Zara—and even more excited for everything ahead. #InternalMedicine #Match2027 #MedTwitter #MedEd #IMG #ERAS2027 #MedicalEducation #Leadership #HematologyOncology @MedNewsWeek @ProjectImg @ProjectImg @zarabaloc

CML care is evolving. 🎙️ In this @MedNewsWeek × @oncodaily episode, Jorge Cortes, MD, explores modern treatment algorithms, TKIs, molecular monitoring, treatment-free remission, resistance, and AI-driven personalized care. Watch: piped.video/watch?v=dtWA2bQ2… #CML #MedNewsWeek

The future of cell & gene therapy won’t be defined by innovation alone—it will be defined by who can actually access it. Thrilled to be joining Technology Networks as a Featured Speaker on September 24 for a conversation at the intersection of two fields rapidly reshaping medicine: AI and cell & gene therapy. My presentation, “AI-Enabled Standardization for Scalable Cell & Gene Therapy Trial Matching,” will explore a challenge I believe we urgently need to solve: How do we take extraordinary scientific innovation and make sure the right patient can actually find—and reach—the right clinical trial? The next frontier of AI in medicine isn’t simply generating better answers. It’s building tools that can break down barriers, standardize complex decision-making, expand access to clinical trials, and help move transformative therapies from possibility to patients. That is the future I’m incredibly excited to help build. I’m deeply grateful to Dr. Arturo Bonilla for his outstanding mentorship, guidance, and belief in this work, and to Dr. Chandler Park for his continued mentorship and support. Having mentors who challenge you to think bigger—and then help you turn those ideas into something meaningful—is invaluable. And a huge thank you to Technology Networks for providing a global platform to have this conversation. 📅 September 24, 2026 11:00 AM ET Free Registration: technologynetworks.com/tn/we… If you work in AI, oncology, clinical trials, cell & gene therapy, or health equity—or simply want to see where these worlds are converging—I hope you’ll join me. The science is moving fast. Our ability to connect patients to it needs to move even faster. #ArtificialIntelligence #CellTherapy #GeneTherapy #ClinicalTrials #Oncology #PrecisionMedicine #AIinHealthcare #HealthEquity #ClinicalResearch

🩸 CML HAS CHANGED. HAVE OUR TREATMENT ALGORITHMS KEPT UP? The era of simply choosing a TKI and monitoring response is behind us. Today, treating chronic myeloid leukemia means navigating an increasingly complex set of decisions: Which TKI should you start — and for whom? When should an inadequate response trigger a switch? How should resistance mutations change treatment selection? Where do newer agents fit into sequencing? Who can safely pursue treatment-free remission — and when? At this week's MedNews Week Keynote Conference, we go directly into these questions with Dr. Jorge Cortes, MD, one of the investigators who helped build the evidence base behind modern CML therapy. 🎙️ THE CML EVOLUTION: Mastering Modern Algorithms in Chronic Myeloid Leukemia Dr. Cortes breaks down how CML management has evolved and, more importantly, how to translate that evolution into real-world treatment decisions at the bedside. Now at the University of Alabama at Birmingham, Dr. Cortes has led 90+ Phase I–III clinical trials, authored 1,000+ scientific publications, abstracts, and academic contributions, and held major international leadership roles in CML—including leadership of the International Chronic Myeloid Leukemia Foundation. This isn't just a review of CML. It is an opportunity to learn how one of the field's most influential investigators thinks through the decisions that define modern CML care. 📅 September 16, 2026 ⏰ 12:30 PM ET 🌎 MedNews Week Keynote Conference Catch this episode exclusively on OncoDaily TV: piped.video/watch?v=dtWA2bQ2… From first-line therapy → resistance → sequencing → treatment-free remission. If you treat leukemia—or are training to—this is one conversation worth hearing. MedNews Week | Connecting Medicine Globally. #MedNewsWeek #CML #ChronicMyeloidLeukemia #Leukemia #Hematology #HemeOnc #Oncology #CancerResearch #CancerCare #ClinicalOncology #PrecisionMedicine #TargetedTherapy #TKI #TreatmentFreeRemission #ClinicalTrials #MedicalEducation #HematologyOncology #OncTwitter #MedTwitter #ConnectingMedicineGlobally @oncodaily

Catch this episode exclusively on OncoDaily TV: piped.video/watch?v=dtWA2bQ2…

New paradigms, same mission: better outcomes. @DrKarineTawagi breaks down the evolving landscape of bladder cancer care — exactly the kind of frontline knowledge @MedNewsWeek exists to spread. #UroOnc #BladderCancer #MedEd

Hi #MedTwitter! 👋 I’m Zara Baloch, MBBS, an ECFMG-certified IMG based in Florida, applying to #InternalMedicine for #Match2027. 🔬 Passionate about research, Heme/Onc, medical education & patient advocacy 🎙️ Director of Research & Medical Correspondent at MedNews Week 🎧 Creator & Co-host of Match Confidential Fun fact: A year ago, I never imagined I’d be hosting conferences or interviewing physicians and researchers. Through MedNews Week, I unexpectedly grew to love it, especially the opportunity to learn firsthand from leaders shaping the field. Outside medicine, curiosity describes me best. I love art, museums, nature, ancient civilizations & documentaries (almost always over fiction!). I’m happiest exploring something I haven’t seen or learned about before, from trying freediving to spending hours in a museum. And no matter what city I’m in, I somehow always find a pickleball court. 🏓 I’m also drawn to Stoic philosophy, particularly Marcus Aurelius, and enjoy incorporating lessons from The Daily Stoic into everyday life. “The impediment to action advances action. What stands in the way becomes the way.” -Marcus Aurelius Looking forward to connecting with applicants, residents, faculty & mentors this Match season! AAMC ID: 16315579 @MedNewsWeek @ProjectImg #IMG #ERAS #ECFMG #MedEd #HematologyOncology #match2027 #ERAS2027

@MedNewsWeek x @oncodaily 🧬In this episode, Dr. @jorgecortesmd explores how modern CML management now balances molecular response, treatment selection, tolerability, and long-term quality of life. 🎥Full Episode: piped.video/watch?v=dtWA2bQ2…

A treatment algorithm can tell you the options. It can’t always tell you what’s right for the patient in front of you. That distinction makes this conversation with Dr. @jorgecortesmd on modern CML management worth hearing. 🎥 @MedNewsWeek x @oncodaily: piped.video/dtWA2bQ2nX4?si=1PqK…

CML Care is Moving Toward More Individualized Treatment - Helena Sanchez Coloma @MedNewsWeek oncodaily.com/voices/helena-…

The future of CML treatment is evolving rapidly. Dr. Jorge Cortes, MD @jorgecortesmd, shares expert insights on Chronic #MyeloidLeukemia , clinical decision-making, and the evolving treatment landscape. Watch the keynote: @MedNewsWeek @OncLive piped.video/dtWA2bQ2nX4?is @YLeyfman

Congratulations to Dr. Leyfman on 2 presentations at NCI's Global Cancer Research Conference! We are incredibly proud of your continued commitment to advancing global oncology education, health equity & innovation. Proud to see the MNW mission represented on such a global stage.

Excited to be giving 2 presentations at the 14th Annual Symposium on Global Cancer Research, hosted by the U.S. National Cancer Institute Center for Global Health. This year’s theme, “From Local Discovery to Global Impact,” reflects a mission deeply aligned with our work: translating innovation into meaningful improvements in cancer care that extend across geographic, educational, and resource settings. I’m looking forward to presenting our work on: 🔹From Digital Access to Global Impact: A Virtual Oncology Education Model for Reducing Cancer Knowledge Disparities 🔹 Toward Equitable Precision Oncology: Real-World Validation of an AI-Powered Trial Matching Platform While these projects approach the problem from different perspectives, they share a central question: How can we harness education, technology, and responsible innovation to make cancer knowledge, clinical research, and precision oncology more accessible and equitable worldwide? I’m incredibly grateful to Dr. Chandler Park and Dr. Arturo Loaiza-Bonilla for their mentorship, guidance, and continued support. I also want to recognize the entire MedNews Week team for their hard work, diligence, and continued commitment to combating disparities in oncology education globally. This work is possible because of a team that consistently believes that where someone lives or trains should not determine their access to high-quality oncology education and knowledge. Looking forward to an engaging discussion about the future of equitable cancer care, global oncology, and responsible innovation—and how we can turn local discoveries into global impact. #GlobalOncology #CancerResearch #HealthEquity #PrecisionOncology #ArtificialIntelligence #ClinicalTrials #CancerEducation #GlobalHealth #NCI #ASGCR2026

If you’re applying for residency this cycle, the phrase “red flag” can create a lot of anxiety. We wanted to address that directly in Episode 2 of Match Confidential, a MedNews Week series. What actually counts as a red flag? What just needs context? What can still be strengthened after submission? And when is it better to adjust your strategy? Dr. Christopher Bray (@docbraymd) joined Adeena Musheer (@MusheerAdeena) and me to talk through lower Step scores, prior attempts, year of graduation, gaps, USCE, program filters, advocacy, signals, technology-assisted review, and what applicants can realistically do next. Really grateful to Dr. Bray for sharing such practical advice from his years of experience in residency leadership and mentoring applicants. I hope applicants navigating this cycle find the conversation useful and come away with a clearer sense of what they can focus on next. Match Confidential | Episode 2: Residency Red Flags, Filters & Second Chances 🎥 Watch here: piped.video/seXgZxNEcnU?si=fMC1… @MedNewsWeek @YLeyfman #ResidencyMatch #ERAS2027 #MatchConfidential #MedNewsWeek

Such valuable insights from @DrKarineTawagi on navigating career transitions, mentorship, and the art of knowing when to say yes vs. no! 💡 Catch the full conversation from @MedNewsWeek x @oncodaily hosted by @YLeyfman: piped.video/xNpco_Cod_U

An insightful discussion with @DrKarineTawagi on the rapidly evolving treatment landscape of muscle-invasive bladder cancer, now highlighted through the MedNews Week comic series. Watch here @MedNewsWeek x @oncodaily: piped.video/xNpco_Cod_U?si=icJx…